What's a 'black box' warning? A pharmacologist explains how these labels protect patients
A "black box" warning on a health product sounds pretty scary—maybe even more so when it's suddenly being taken off the packaging.
Nov 13, 2025
0
0
Heterocyclic Compounds: News and Research on Phthalimides
MeSH tree: D03.633.100.513.750
Brain scans reveal action-based organization in people born without hands
Conventional wisdom among neuroscientists suggests that the brain's motor functions are organized around the body, meaning certain brain areas control the hand; others the foot. An emerging alternative theory is that parts ...
Aug 20, 2025
0
38
FDA approves Monjuvi for relapsed, refractory follicular lymphoma
The U.S. Food and Drug Administration has approved Monjuvi (tafasitamab-cxix) for the treatment of adult patients with relapsed or refractory follicular lymphoma.
Jun 23, 2025
0
0
Discovery of key mechanism could combat lenalidomide resistance in multiple myeloma
A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore has uncovered a key mechanism behind lenalidomide resistance in multiple myeloma ...
Apr 10, 2025
0
0
Lower dexamethasone dose does not impair survival in multiple myeloma
For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not negatively impact survival, according to a study published online Jan. 2 in Blood.
Jan 24, 2025
0
0
Advanced cancer models could help personalize lymphoma treatments
Scientists at EPFL have developed "lymphomoids," a pioneering cancer model that preserves the structure and multicellular composition of lymphoma tumors in the lab. Lymphomoids offer an innovative way to test the efficacy ...
Dec 18, 2024
0
13
Medication decisions in pregnancy: Experts propose an ethics-based, evidence-backed approach
Most women use medication during pregnancy. Yet, selecting appropriate drugs and doses is challenging. In an article in The Lancet, physicians and researchers from the Radboud university medical center, Maastricht UMC+, Imperial ...
Oct 31, 2024
0
14
Study links polygenic scores to hypertension treatment outcomes
University of Alabama at Birmingham researchers have discovered that a genetic risk score can predict how Black individuals with hypertension respond to the blood pressure medication chlorthalidone and their likelihood of ...
New CAR-T cells offer on-demand control for cancer treatment
Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that can be switched on to varying degrees of intensity and then switched off on demand ...
Oct 22, 2024
0
78
Clinical trial demonstrates success in treating rare blood disorder
A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than one in 5,000 people worldwide.
Sep 18, 2024
0
17
